Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
10/09/2008 | US20080248475 Methods and Compositions for Modulating Gluconeogenesis Using PGC-1 |
10/09/2008 | US20080248471 Methods for disease detection |
10/09/2008 | US20080248468 Using vectors comprising RNA interfering sequences to control geneic expression in cells; utilizing nerve growth factor receptor as biomarker to confirm transfection |
10/09/2008 | US20080248464 Method of DNA Shuffling with Polynucleotides Produced by Blocking or Interrupting a Synthesis or Amplification Process |
10/09/2008 | US20080248188 maize starch,has an increased phosphate content and/or a modified phosphorylation pattern and/or an increased final viscosity in an RVA profile and/or a reduced peak temperature in DSC analysis and/or an increased gel strength in texture analysis compared with starch from non-genetically modified plant |
10/09/2008 | US20080248160 Xylanases, nucleic acids encoding them and methods for making and using them |
10/09/2008 | US20080248068 Use of Flagellin as an Adjuvant for Vaccine |
10/09/2008 | US20080248066 Free-living microbes are provided in which the nucleic acid has been modified so that the microbe is attenuated for proliferation and/or which comprise genetic mutations that attenuate the ability of the microbe to repair its nucleic acid. Methods using the modified microbes for the activation antigens |
10/09/2008 | US20080248064 Localization and Characterization of Flavivirus Envelope Gylcoprotein Cross-Reactive Epitopes and Methods for their Use |
10/09/2008 | US20080248045 Polypeptides having a triggering nk activity and biological applications |
10/09/2008 | US20080248044 Polyepitopic protein fragments of the e6 and e7 proteins of hpv, their production and their use particularly in vaccination |
10/09/2008 | US20080248043 Antibodies to SARS coronavirus |
10/09/2008 | US20080248041 Using membrane protein as evauluative tool in identifying modulators for prevention and treatment of neuropathic pain and nervous system disorders |
10/09/2008 | US20080248040 Nucleotide sequences coding membrane protein segments for use in identifying modulators for prevention and treatment of epilepsy, cancer, pain and sleep disorders |
10/09/2008 | US20080248031 Cell surface molecule mediating cell adhesion and signal transmission |
10/09/2008 | US20080248029 Prevention and treatment of amyloidogenic diseases |
10/09/2008 | US20080248023 Treating and preventing amyloid A amyloidosis via enhancing immune response to amyloid A light-chain protein or serum amyloid A precursor protein |
10/09/2008 | US20080248020 Variant lyase for use in treatment and prevention of cell proliferative disorders |
10/09/2008 | US20080248019 Hydrolase which utilizes linkage-specific cleavage of galactose as part of therapeutic regimen for treatment of cell proliferative disorders; antitumor agents |
10/09/2008 | US20080248018 Recombinant human arginase functioning as arginine depleting agent in treatment of cell proliferative disorders |
10/09/2008 | US20080248016 Novel Iaccase Enzymes and Their Uses |
10/09/2008 | US20080248010 Protein kinase for use as tool in identifying modulators for treatment of diabetes |
10/09/2008 | US20080248009 Using antisense agents specific to apoptosis-associated nucleic acids to modulate apoptosis in transplanted tissues; treating cell proliferative disorders |
10/09/2008 | US20080248008 Transferase inhibitory mimetic for use in treatment and prevention of immunosuppressive, cell proliferative and autoimmune disorders |
10/09/2008 | US20080248007 Nucleotide sequences coding protein associated with immune response for use in identifying modulators for prevention and treatment of immunodeficiency, autoimmue and inflammatory disorders |
10/09/2008 | US20080248006 Propagating osteogenic or bone precursor cells in nutrient broth; tissue engineering and repair; regenerative medicine; treating and/or preventing bone disorders |
10/09/2008 | US20080247996 Methods of treating neoplasia with combination target cell-specific adenovirus, chemotherapy and radiation |
10/09/2008 | US20080247955 Detecting secreted phosphoprotein-1 and/or biomarkers; autoimmune diseases; antibodies; RNA interference |
10/09/2008 | US20080247944 Human monoclonal antibodies; encoded by nucleic acids; anticancer agents |
10/09/2008 | DE102007016534A1 Neuer Expressionsvektor von Codon-optimierten Genen eines Arabinose-Stoffwechselweges zur Arabinose-Umsetzung in Hefe New expression vector of codon-optimized genes of an arabinose pathway for arabinose conversion in yeast |
10/09/2008 | CA2762982A1 Glycosylation of molecules |
10/09/2008 | CA2682712A1 Method for producing ceramide in transformed cells using the sphingolipid-.delta.4-desaturase attached with an endoplasmic reticulum localization signal |
10/09/2008 | CA2682591A1 Compositions, kits and related methods for the detection and/or monitoring of pseudomonas aeruginosa |
10/09/2008 | CA2682482A1 Methods of gene amplification and expression |
10/09/2008 | CA2682232A1 Detecting a g to a missense mutation in the cypb gene for the identification of the hereditary equine reginonal dermal asthenia |
10/09/2008 | CA2682227A1 Insecticidal proteins |
10/09/2008 | CA2682199A1 Chloroplasts engineered to express pharmaceutical proteins in edible plants |
10/09/2008 | CA2682161A1 Compositions and methods for inhibiting expression of a gene from the ebola |
10/09/2008 | CA2682100A1 Transgenic animal models of disease |
10/09/2008 | CA2682095A1 Method for producing transgenic surface layer chimeric plant |
10/09/2008 | CA2681614A1 Transgenic plants containing soluble cell wall polysaccharides |
10/09/2008 | CA2681581A1 Recombinant expression vector elements (reves) for enhancing expression of recombinant proteins in host cells |
10/08/2008 | EP1978366A1 Fluorescent label for biomaterial and method of fluorescent-labeling biomaterial |
10/08/2008 | EP1978351A2 Instrument for monitoring polymerase chain reaction of dna |
10/08/2008 | EP1978110A1 System, method and apparatus for transgenic and targeted mutagenesis screening |
10/08/2008 | EP1978108A2 Single nucleotide polymorphisms predicting cardiovascular disease and medication efficacy |
10/08/2008 | EP1978098A2 Use of multiple recombination sites with unique specificity in recombinational cloning |
10/08/2008 | EP1978097A1 Regulation of transcription factor, NF-IL6/LAP |
10/08/2008 | EP1978096A1 Novel oligonucleotide and nf-kappa b decoy comprising the same |
10/08/2008 | EP1978095A1 Chimeric receptor proteins for controlling signal transduction and ligands binding thereto |
10/08/2008 | EP1978093A1 Method of crosslinking two objects of interest |
10/08/2008 | EP1978092A1 Mutant luciferases |
10/08/2008 | EP1978091A1 Mutant luciferases |
10/08/2008 | EP1978085A1 Gene expression analysis tool |
10/08/2008 | EP1978036A1 A mycobacterium tuberculosis fusion protein and uses thereof |
10/08/2008 | EP1978035A1 Anti-amyloid antibodies and their use in diagnosis and therapy of amyloid diseases |
10/08/2008 | EP1978033A2 Human antibodies derived from immunized xenomice |
10/08/2008 | EP1978031A2 Tropoelastin derivatives |
10/08/2008 | EP1978029A2 Secreted and transmembrane polypeptides and nucleic acids endoding the same |
10/08/2008 | EP1978027A1 Full-length infectious cDNA clones of tick borne flavivirus |
10/08/2008 | EP1977003A2 Methods and means related to diseases |
10/08/2008 | EP1976992A1 Methods and compositions for the detection and isolation of ligands |
10/08/2008 | EP1976991A1 Fusion proteins that contain natural junctions |
10/08/2008 | EP1976990A2 Chimeric, hybrid and tandem polypeptides of meningococcal nmb1870 |
10/08/2008 | EP1976989A1 A novel mrna splice variant of the doublecortin-like kinase gene and its use in diagnosis and therapy of cancers of neuroectodermal origin |
10/08/2008 | EP1976988A1 C-terminal exon 5.4 of runx1/aml1 |
10/08/2008 | EP1976987A1 Novel cancer-associated antigen |
10/08/2008 | EP1976986A2 Sirna compositions promoting scar-free wound healing of skin and methods for wound treatment |
10/08/2008 | EP1976983A2 Fad-2 mutants and high oleic plants |
10/08/2008 | EP1976877A2 Monoclonal antibodies against amyloid beta protein and uses thereof |
10/08/2008 | EP1976868A2 Spider silk proteins and methods for producing spider silk proteins |
10/08/2008 | EP1976566A2 Compositions and methods for altering rnai |
10/08/2008 | EP1976564A2 Immuno-rna-constructs |
10/08/2008 | EP1976554A2 De-n-acetyl sialic acid antigens, antibodies thereto, and methods of use in cancer therapy |
10/08/2008 | EP1976470A2 Laser energy calibration based on optical measurement |
10/08/2008 | EP1791861A4 Protein regulating leaf longevity of plants, the gene thereof and their use |
10/08/2008 | EP1730173A4 Nucleic acid molecules encoding novel murine low-voltage activated calcium channel proteins, designated-alpha 1h, encoded proteins and methods of use thereof |
10/08/2008 | EP1713918A4 Oligonucleotide for genotyping of mycoplasma, microarray comprising the oligonucleotide, and method for detection of species using the microarray |
10/08/2008 | EP1611247B1 Cyp2s1 as target for diagnosis and therapy of skin diseases |
10/08/2008 | EP1579186A4 Identification of kinase inhibitors |
10/08/2008 | EP1556408B1 Membrane protein library for proteome analysis and method for preparing same |
10/08/2008 | EP1546414B1 Hcv assay |
10/08/2008 | EP1523678B1 Functional screening method involving protein translocation/redistribution |
10/08/2008 | EP1507795B1 Tumour-associated peptides that bond to mhc molecules |
10/08/2008 | EP1485346B1 Novel positively charged lipids and liposomes comprising the positively charged lipids |
10/08/2008 | EP1407661B1 Transgenic animal transformed using green fluorescent protein gene |
10/08/2008 | EP1349870B1 Compositions for the therapy and diagnosis of ovarian cancer |
10/08/2008 | EP1262548B1 Polypeptide inducing apoptosis |
10/08/2008 | EP1244775B1 Molecular display on multimeric protein scaffolds derived from the e2 component of the alpha-ketoacid dehydrogenase |
10/08/2008 | EP1199565B1 Diagnostics and remedies for diseases with participation of macrocytes/macrophages |
10/08/2008 | EP1163364B1 Screening method involving mgdg synthase |
10/08/2008 | EP1157105B8 Regulatory constructs comprising intron 3 of prostate specific membrane antigen gene |
10/08/2008 | EP1141334B1 Human glycosylphosphatidylinositol specific phospholipase d variants and uses thereof |
10/08/2008 | EP1137762B1 Treatment of pompe's disease |
10/08/2008 | EP1076708B1 Method for the production of 1,3-propanediol by recombinant organisms comprising genes for vitamin b 12 transport |
10/08/2008 | EP1071779B1 Vertebrate patched-2 protein |
10/08/2008 | EP1032667B1 Platelet specific antigens and their pharmacological uses |
10/08/2008 | EP1020518B1 Transporter genes |
10/08/2008 | EP0969014B1 Beta-ketoacyl-acp-synthetase ii enzyme and gene encoding the same |
10/08/2008 | EP0876095B1 Electroporation-mediated molecular transfer in intact plants |